“The Autologous CaTeVac Dendritic Cell Vaccine in Patients With Melanoma: Final Results of the DENDRON-01 Study”. Voprosy Onkologii, vol. 71, no. 4, Sept. 2025, p. OF-2437, https://doi.org/10.37469/0507-3758-2025-71-4-OF-2437.